Lymphoma, Large B-Cell, DiffuseLymphoma, B-CellLymphomaLymphoma, Non-HodgkinAntineoplastic Combined Chemotherapy ProtocolsLymphoma, FollicularLymphoma, T-CellLymphoma, B-Cell, Marginal ZoneGerminal CenterB-LymphocytesProto-Oncogene Proteins c-bcl-6Lymphoma, T-Cell, PeripheralLymphoma, Large-Cell, ImmunoblasticChemotherapy, AdjuvantCyclophosphamideDoxorubicinAntibodies, Monoclonal, Murine-DerivedBurkitt LymphomaAntigens, CD79VincristineMediastinal NeoplasmsHodgkin DiseaseAntigens, CD20Treatment OutcomeMyelin and Lymphocyte-Associated Proteolipid ProteinsPrednisoneEpstein-Barr Virus InfectionsAntigens, CD40PrognosisCD40 LigandAntigens, CD8ImmunophenotypingAntigens, CD3Translocation, GeneticImmunohistochemistryFatal OutcomeAntineoplastic AgentsLymphoma, Mantle-CellCombined Modality TherapyLymphoproliferative DisordersAntigens, CD34Lymphoma, T-Cell, CutaneousAntigens, CD44Immunoglobulin Heavy ChainsLymphoma, AIDS-RelatedCARD Signaling Adaptor ProteinsChemotherapy-Induced Febrile NeutropeniaB-Lymphocyte SubsetsAntigens, CD28CD4-CD8 RatioCell Line, TumorHerpesvirus 4, HumanLymphoma, Large-Cell, AnaplasticCisplatinAntigens, CD5Antigens, CD19Antigens, CDTumor Markers, BiologicalSurvival AnalysisGene Expression Regulation, NeoplasticCD4-Positive T-LymphocytesDisease-Free SurvivalAntigens, CD38Antigens, CD30Proto-Oncogene Proteins c-bcl-2EtoposideNeoplasm StagingSurvival RateAntigens, CD14Antigens, CD80Gene Expression ProfilingPolymerase Chain ReactionAntigens, CD95DNA-Binding ProteinsNeoadjuvant TherapyFlow CytometryAntibodies, MonoclonalAntigens, CD1Remission InductionMethotrexateBreast NeoplasmsLymphocyte ActivationAntigens, CD2SpleenRetrospective StudiesDrug Administration ScheduleAntigens, CD56Lung NeoplasmsBleomycinImmunoglobulin MMutationAntigens, CD86Lymph NodesVinblastineTransplantation, AutologousAntigens, CD24Antigens, CD18Neoplasm Recurrence, LocalNeoplasmsTime Factors